Wegovy (Semaglutide 2.4 mg) Nausea: When to Call the Doctor At a glance Nausea is the most common Wegovy side effect, reported by 44% of participants in the STEP-1 trial Most episodes are mild to moderate and peak during dose-escalation phases Median time to resolution is 8 to 12 weeks after reaching maintenance dose Severe nausea leading to treatment discontinuation occurred in 2.4% of STEP-1 participants Delayed gastric emptying and direct brainstem GLP-1 receptor activation drive the symptom Red-flag signs include inability to keep liquids down for 24+ hours, hematemesis, or severe epigastric pain Eating smaller meals, staying upright after eating, and avoiding high-fat foods reduce symptom burden Dose escalation follows a 16-week titration schedule designed to minimize GI side effects Ondansetron or other antiemetics may be prescribed for refractory nausea FDA labeling recommends discontinuation if nausea is persistent and clinically significant How Common Is Nausea on Wegovy
While Cardenas said his husband, Jeffer Jimenez, 37, uses GLP-1s primarily for weight loss, Jimenezs prescription is for his diabetes, so the couple hoped to continue receiving coverage through Medi-Cal
Look Good Feel Better Program www.lookgoodfeelbetter.org 800-395-LOOK (800-395-5665) This program offers workshops to learn things you can do to help you feel better about your appearance
The key difference is that the Wegovy pill requires a strict 30-minute fasting window each morning while orforglipron can be taken any time of day with or without food
The corollary is that the temptation to increase the dose because nothing is happening yet is exactly backwards the protocol is built on consistency, and week 2 is not where you judge it
Lipotropic injections are a different category altogether, typically containing a combination of compounds claimed to promote fat metabolism and weight loss
